Bionano Genomics (BNGO) Receivables - Net (2017 - 2026)

Bionano Genomics' Receivables - Net history runs 10 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• In Q1 2026, Receivables - Net rose 23.76% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (up 23.76% YoY), while the FY2025 annual figure was $5.2 million, up 6.29% from the prior year.
• Receivables - Net came in at $4.2 million for Q1 2026 at Bionano Genomics, down from $5.2 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $9.3 million in Q4 2023 to a low of $3.4 million in Q1 2025.
• A 5-year average of $6.1 million and a median of $6.0 million in 2022 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net soared 46.39% in 2022 and slumped 59.65% in 2025, its largest moves.
• Bionano Genomics' Receivables - Net stood at $7.0 million in 2022, then jumped by 32.71% to $9.3 million in 2023, then tumbled by 47.32% to $4.9 million in 2024, then grew by 6.29% to $5.2 million in 2025, then retreated by 20.45% to $4.2 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $4.2 million, $5.2 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison